Analogic and Philips strike new deal

Article

Analogic of Peabody, MA, has struck a multiyear, multimillion dollar agreement to develop and provide advanced engineering and manufacturing services to Philips Medical Systems. The agreement calls for Analogic to develop new subassemblies/components for

Analogic of Peabody, MA, has struck a multiyear, multimillion dollar agreement to develop and provide advanced engineering and manufacturing services to Philips Medical Systems. The agreement calls for Analogic to develop new subassemblies/components for Philips, while continuing to supply data acquisition systems, spare parts, and engineering services for the CT systems previously provided by Analogic and sold by Philips. Analogic will also continue supplying a range of patient monitoring equipment to Philips. Until Philips' acquisition of Marconi Medical last year, Analogic had been the Dutch company's sole supplier of midrange CT systems. After the Marconi purchase, however, Philips and Analogic decided to restructure the existing CT contract and develop a new agreement.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.